Jan 17, 2017 13:02 pm UTC| Business
Fourth Cohort of Patients Continues to Show Clinically Meaningful Responses in the Evaluation of GEN-1, A Novel IL-12 DNA-based Immunotherapy, in Combination with the Standard of Care LAWRENCEVILLE, N.J., Jan. 17, 2017 ...
Jan 17, 2017 13:02 pm UTC| Business
DUBLIN, Calif., Jan. 17, 2017 -- Callidus Software Inc. (NASDAQ:CALD), a global leader in cloud-based sales, marketing, learning and customer experience solutions, announced today a new strategic OEM agreement with SAP...
Jan 17, 2017 13:02 pm UTC| Business
DUBLIN, Calif., Jan. 17, 2017 -- Callidus Software Inc. (NASDAQ:CALD), a global leader in cloud-based sales, marketing, learning and customer experience solutions, announced today a new strategic OEM agreement with SAP...
Jan 17, 2017 13:02 pm UTC| Business
DUBLIN, Calif., Jan. 17, 2017 -- Callidus Software Inc. (NASDAQ:CALD), a global leader in cloud-based sales, marketing, learning and customer experience solutions, announced today a new strategic OEM agreement with SAP...
Jan 17, 2017 13:02 pm UTC| Business
WATERTOWN, Mass., Jan. 17, 2017 -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today announced dosing of the first patient in IGNITE3, the Company’s phase 3 clinical trial evaluating the efficacy and safety of...
Jan 17, 2017 13:02 pm UTC| Business
WATERTOWN, Mass., Jan. 17, 2017 -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today announced dosing of the first patient in IGNITE3, the Company’s phase 3 clinical trial evaluating the efficacy and safety of...
Jan 17, 2017 13:02 pm UTC| Business
WATERTOWN, Mass., Jan. 17, 2017 -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today announced dosing of the first patient in IGNITE3, the Company’s phase 3 clinical trial evaluating the efficacy and safety of...